Cell and Gene Therapy Catapult’s Post

Yesterday Jeanette Evans, Chief Business Officer at the Cell and Gene Therapy Catapult spoke at the 24-hour WIAT Global Virtual Event! Jeanette spoke in the morning joining a panel of experts discussing: 'Exploring the UK's leadership in cell and gene therapy innovation and the implications faced in Europe'. In case you missed it, learn more about the Cell and Gene Therapy Catapult: https://buff.ly/3VkAqJ5 #AdvancedTherapies #CellTherapies #GeneTherapies

Breaking Boundaries in Process Development: Unleashing the Power of Stirred-Tank Bioreactors for Cell and Gene Therapies: In this webinar sponsored by Eppendorf, experts from industry and academia will share their insights and experiences as they lay out the potential of stirred-tank bioreactors for cell and gene therapy development and manufacturing. Watch now: https://lnkd.in/gePmuk5E

Did you catch the latest episode of Molecule to Market with Andy Holt, CCO of Viralgen Vector Core? 🎙️ In this episode, Raman Sehgal and Andy discuss: 👉 Growing a CDMO while dealmaking in a gene therapy company…at the same time 👉 Selling a revenue-generating therapy company to Bayer during the pandemic 👉 The challenges of manufacturing AAV gene therapies and why the next generation of CGT CDMOs need a voice at the table 🎧 Listen below, you don't want to miss it! #CDMO #AAV #GeneTherapy

Did you know that we provide integrated cell and gene therapy (CGT) software systems for the orchestration, precise management, control and tracking of cell and gene therapies for clinical trials and commercial launches? In fact, we have 100+ live global site deployments, 20+ therapy types, and 1000+ patients enrolled on our systems. Learn more about who we are and what we do in this datasheet: https://loom.ly/4-r6Qjw #CGT #CellandGeneTherapy #AdvancedTherapies

Today at #ASGCT2024, Peter Cameron is presenting on our AI-powered approach to custom-building de novo gene editors.  If #OpenCRISPR piqued your interest - or if you have another ambitious protein design campaign in mind - come find me or Anna Chase! 🎤 Language Models Generate Novel Genome Editors from scratch 📅 2 pm EST in Ballroom 1 #AI #GenerativeAI #ProteinDesign #CRISPR

Potency #bioassays remain a hot topic for innovative cell and gene therapy drugs.💉Using our QC assays (flow cytometry, cell-based potency, automated imaging and analysis tools), we can determine your product’s: 🦠Delivery of transgene to cell 🧬Transgene expression 💉Successful translation into functional product This is essential at multiple stages of the product life cycle, including future clinical trials. Want to learn what #potencyassays can do for you? Book a call with our science team: https://buff.ly/3Q4D4A7 #celltherapy #genetherapy #bioassays #bioanalyticallab #bioanalysis #CGT

Do you know when companion diagnostics (CDx) are needed for your cell and gene therapy programs? Or what kind of testing is required and how to choose the right lab partner for a CDx assay? In our blog, you’ll learn from Labcorp subject matter experts as they answer key questions you may have about developing CDx for your cell and gene therapy programs. Learn more: #CellandGeneTherapy #CompanionDiagnostics

Do you know when companion diagnostics (CDx) are needed for your cell and gene therapy programs? Or what kind of testing is required and how to choose the right lab partner for a CDx assay? In our blog, you’ll learn from Labcorp subject matter experts as they answer key questions you may have about developing CDx for your cell and gene therapy programs. Learn more: https://lnkd.in/gB6JvD-T #CellandGeneTherapy #CompanionDiagnostics

Questions about applying #computervision in a commercial production setting?  Listen to Taylor Chartier’s presentation the morning of March 6th at #IFPAC to hear about common use cases and compliance to improve cell and gene therapy quality control. Link shared below in comments.  See you in the audience or afterwards at our booth! #genetherapy #ai #qualitycontrol #gxp

How can you be sure you're meeting regulatory standards for residual host cell DNA in your cell or gene therapy product? Find out here: https://lnkd.in/gVEf9acS HEK293 cells are a commonly used platform for cell and gene therapy production, but traces of DNA from these host cells can be a dangerous potential contaminant in therapeutic products. Droplet Digital PCR technology offers an efficient and sensitive approach for residual host cell DNA detection, enabling absolute quantification of nucleic acid contaminants. Bio-Rad's Vericheck ddPCR HEK293 Residual DNA Detection Kits support a user-friendly workflow for precise measurement of host cell DNA to ensure every product batch adheres to regulatory guidelines. Learn more: https://lnkd.in/grUJZFea #CellTherapy #GeneTherapy #QualityControl #ddPCR